Follow up after IMRT in oral cavity cancer: update

<p><b>Abstract</b></p> <p><b>Purpose</b></p> <p>Except for early stages (T1/2 N0), the prognosis for patients with oral cavity cancer (OCC) is known to be worse than for those with pharyngeal carcinoma. While definitive intensity modulated radiat...

Full description

Bibliographic Details
Main Authors: Studer Gabriela, Brown Michelle, Bredell Marius, Graetz Klaus W, Huber Gerhard, Linsenmeier Claudia, Najafi Yousef, Riesterer Oliver, Rordorf Tamara, Schmid Stephan, Glanzmann Christoph
Format: Article
Language:English
Published: BMC 2012-06-01
Series:Radiation Oncology
Subjects:
Online Access:http://www.ro-journal.com/content/7/1/84
_version_ 1818777218051997696
author Studer Gabriela
Brown Michelle
Bredell Marius
Graetz Klaus W
Huber Gerhard
Linsenmeier Claudia
Najafi Yousef
Riesterer Oliver
Rordorf Tamara
Schmid Stephan
Glanzmann Christoph
author_facet Studer Gabriela
Brown Michelle
Bredell Marius
Graetz Klaus W
Huber Gerhard
Linsenmeier Claudia
Najafi Yousef
Riesterer Oliver
Rordorf Tamara
Schmid Stephan
Glanzmann Christoph
author_sort Studer Gabriela
collection DOAJ
description <p><b>Abstract</b></p> <p><b>Purpose</b></p> <p>Except for early stages (T1/2 N0), the prognosis for patients with oral cavity cancer (OCC) is known to be worse than for those with pharyngeal carcinoma. While definitive intensity modulated radiation therapy (IMRT)-chemotherapy affords loco-regional control rates (LRC) of approximately 80% in advanced pharyngeal cancer, corresponding rates are reported to be much lower for OCC. The aim of this work was to evaluate loco-regional disease control and overall survival (OAS) in a relatively large OCC patient cohort treated in the IMRT era.</p> <p><b>Methods and materials</b></p> <p>Between October 2002 and June 2011, 160 OCC patients were treated with curative intention IMRT at our department. 122 patients (76%) were referred with primary disease and 38 patients (24%) with a recurrent OCC at least 3 months after surgery alone. Definitive IMRT was performed in 44/160 patients (28%), whilst 116 patients underwent previous surgery. Simultaneous systemic therapy was administered in 72%.</p> <p><b>Results</b></p> <p>Patients with postoperative IMRT (+/−systemic therapy) with R0-1 status (n = 99) reached significantly higher LRC/OAS rates than patients following IMRT for macroscopic disease (n = 61), with 84%/80% versus 38%/33% at 3 years, respectively (p < 0.0001). This was found in patients treated for initial, as well as recurrent, disease. Less than 2% persisting grade 3/4 late effects were observed.</p> <p><b>Conclusions</b></p> <p>IMRT for R0-1 situations translated into a highly significant superior LRC and OAS compared to the IMRT cohort treated for macroscopic disease. Treatment was well tolerated.</p>
first_indexed 2024-12-18T11:25:20Z
format Article
id doaj.art-53ba0a734fd84fb4a9c72ad6eb398dcf
institution Directory Open Access Journal
issn 1748-717X
language English
last_indexed 2024-12-18T11:25:20Z
publishDate 2012-06-01
publisher BMC
record_format Article
series Radiation Oncology
spelling doaj.art-53ba0a734fd84fb4a9c72ad6eb398dcf2022-12-21T21:09:43ZengBMCRadiation Oncology1748-717X2012-06-01718410.1186/1748-717X-7-84Follow up after IMRT in oral cavity cancer: updateStuder GabrielaBrown MichelleBredell MariusGraetz Klaus WHuber GerhardLinsenmeier ClaudiaNajafi YousefRiesterer OliverRordorf TamaraSchmid StephanGlanzmann Christoph<p><b>Abstract</b></p> <p><b>Purpose</b></p> <p>Except for early stages (T1/2 N0), the prognosis for patients with oral cavity cancer (OCC) is known to be worse than for those with pharyngeal carcinoma. While definitive intensity modulated radiation therapy (IMRT)-chemotherapy affords loco-regional control rates (LRC) of approximately 80% in advanced pharyngeal cancer, corresponding rates are reported to be much lower for OCC. The aim of this work was to evaluate loco-regional disease control and overall survival (OAS) in a relatively large OCC patient cohort treated in the IMRT era.</p> <p><b>Methods and materials</b></p> <p>Between October 2002 and June 2011, 160 OCC patients were treated with curative intention IMRT at our department. 122 patients (76%) were referred with primary disease and 38 patients (24%) with a recurrent OCC at least 3 months after surgery alone. Definitive IMRT was performed in 44/160 patients (28%), whilst 116 patients underwent previous surgery. Simultaneous systemic therapy was administered in 72%.</p> <p><b>Results</b></p> <p>Patients with postoperative IMRT (+/−systemic therapy) with R0-1 status (n = 99) reached significantly higher LRC/OAS rates than patients following IMRT for macroscopic disease (n = 61), with 84%/80% versus 38%/33% at 3 years, respectively (p < 0.0001). This was found in patients treated for initial, as well as recurrent, disease. Less than 2% persisting grade 3/4 late effects were observed.</p> <p><b>Conclusions</b></p> <p>IMRT for R0-1 situations translated into a highly significant superior LRC and OAS compared to the IMRT cohort treated for macroscopic disease. Treatment was well tolerated.</p>http://www.ro-journal.com/content/7/1/84IMRT in oral cavity cancerDefinitive IMRT for oral cavity cancerPrognostic parameter in oral cavity cancerSalvage treatment for recurrent oral cavity cancerRecurrent oral cavity cancer
spellingShingle Studer Gabriela
Brown Michelle
Bredell Marius
Graetz Klaus W
Huber Gerhard
Linsenmeier Claudia
Najafi Yousef
Riesterer Oliver
Rordorf Tamara
Schmid Stephan
Glanzmann Christoph
Follow up after IMRT in oral cavity cancer: update
Radiation Oncology
IMRT in oral cavity cancer
Definitive IMRT for oral cavity cancer
Prognostic parameter in oral cavity cancer
Salvage treatment for recurrent oral cavity cancer
Recurrent oral cavity cancer
title Follow up after IMRT in oral cavity cancer: update
title_full Follow up after IMRT in oral cavity cancer: update
title_fullStr Follow up after IMRT in oral cavity cancer: update
title_full_unstemmed Follow up after IMRT in oral cavity cancer: update
title_short Follow up after IMRT in oral cavity cancer: update
title_sort follow up after imrt in oral cavity cancer update
topic IMRT in oral cavity cancer
Definitive IMRT for oral cavity cancer
Prognostic parameter in oral cavity cancer
Salvage treatment for recurrent oral cavity cancer
Recurrent oral cavity cancer
url http://www.ro-journal.com/content/7/1/84
work_keys_str_mv AT studergabriela followupafterimrtinoralcavitycancerupdate
AT brownmichelle followupafterimrtinoralcavitycancerupdate
AT bredellmarius followupafterimrtinoralcavitycancerupdate
AT graetzklausw followupafterimrtinoralcavitycancerupdate
AT hubergerhard followupafterimrtinoralcavitycancerupdate
AT linsenmeierclaudia followupafterimrtinoralcavitycancerupdate
AT najafiyousef followupafterimrtinoralcavitycancerupdate
AT riestereroliver followupafterimrtinoralcavitycancerupdate
AT rordorftamara followupafterimrtinoralcavitycancerupdate
AT schmidstephan followupafterimrtinoralcavitycancerupdate
AT glanzmannchristoph followupafterimrtinoralcavitycancerupdate